ReviewCNS & neurological disorders drug targets2024

Clinical Benefits of Therapeutic Interventions Targeting Mitochondria in Parkinson's Disease Patients.

Matteo Ciocca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.